GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncopeptides AB (LTS:0RN4) » Definitions » DeferredTaxAndRevenue

Oncopeptides AB (LTS:0RN4) DeferredTaxAndRevenue : kr0.00 Mil (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Oncopeptides AB DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Oncopeptides AB's current deferred tax and revenue for the quarter that ended in Mar. 2025 was kr0.00 Mil.

Oncopeptides AB DeferredTaxAndRevenue Historical Data

The historical data trend for Oncopeptides AB's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncopeptides AB DeferredTaxAndRevenue Chart

Oncopeptides AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
DeferredTaxAndRevenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Oncopeptides AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Oncopeptides AB DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of Oncopeptides AB's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncopeptides AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncopeptides AB (LTS:0RN4) » Definitions » DeferredTaxAndRevenue
Comparable Companies
OSTO:CANTA OSTO:ACE OSTO:IRLAB A OSTO:XBRANE OSTO:IVACC OSTO:ELIC OSTO:LIPUM OSTO:GUARD OSTO:XINT XSAT:CESSA VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
ONCO:Sweden OND:Germany
Address
Luntmakargatan 46, Stockholm, SWE, SE-111 37
Website
https://www.oncopeptides.com
Oncopeptides AB is a biotech company focused on the research, development, and commercialization of therapies for difficult-to-treat hematological diseases. The company uses its proprietary Peptide Drug Conjugate (PDC) to develop compounds that rapidly and selectively deliver cytotoxic agents into cancer cells. It has focused on the development of the product candidate Melflufen (Pepaxti), a peptide-conjugated alkylator, belonging to a new class of drugs called Peptidase Enhanced Compounds. Melflufen is intended as an effective treatment for hematological cancers and, in particular, multiple myeloma.

Oncopeptides AB Headlines

No Headlines